University of Massachusetts, Worcester

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Massachusetts, Worcester sits in the top decile of US sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count).

240 total trials 30 currently recruiting 177 completed early-phase tilt top decile by trial count

University of Massachusetts, Worcester: 240 sponsored US clinical trials, 30 recruiting.

University of Massachusetts, Worcester sponsors 240 registered US clinical trials on ClinicalTrials.gov, 30 of them currently recruiting, and 177 completed. 23 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcohol Use Disorder, with 4 trials.

Top-decile sponsor footprint

University of Massachusetts, Worcester ranks in the top decile of sponsors by registered trial count (#136 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 71/100

177 of 191 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

240 total, page 1 of 5

RECRUITING NA

Re-Engineered Discharge for Diabetes Care Transitions

NCT06869057

RECRUITING NA

Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults

NCT07418047

RECRUITING NA

Prehab for Pancreatic Cancer Surgery

NCT07478185

RECRUITING NA

Piloting a Deaf Accessible Pre-Treatment for AUD

NCT07269119

RECRUITING NA

Mothers' Action Project for Child Health

NCT06753669

RECRUITING NA

Pathways to Perinatal Mental Health Equity

NCT06790641

RECRUITING NA

ARISe at UMass Chan

NCT07236034

RECRUITING NA

Social Needs Screening and Chronic Diseases Study (WE CARE)

NCT06903897

RECRUITING NA

Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation

NCT07072039

RECRUITING NA

Early Detection of Gestational Diabetes Mellitus in Pregnancy

NCT05388643

RECRUITING NA

Preventing T2DM After GDM With Immediate Postpartum Screening

NCT06457139

RECRUITING NA

Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy

NCT06835959

RECRUITING

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

NCT06855329

RECRUITING NA

Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings

NCT07208682

RECRUITING NA

Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma

NCT06278922

RECRUITING NA

Effect of Support for Low-Income Mothers of Preterm Infants

NCT06362798

RECRUITING NA

Effects of Erector Spinae Plane Block on Postoperative Pain Following Lumbar Fusion Surgery

NCT06528288

RECRUITING NA

Skilled Nursing Facility at Home Trial

NCT06547645

RECRUITING NA

Medical Residents Learning Weight Management Counseling Skills

NCT06529666

RECRUITING NA

Continuous Glucose Monitor Use in Pregnancy

NCT05317585

RECRUITING NA

Asthma Link Effectiveness Trial

NCT06388460

RECRUITING Phase 4

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

NCT06174116

RECRUITING NA

Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A

NCT06223867

RECRUITING NA

MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick

NCT05968157

RECRUITING

Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study

NCT06522880

RECRUITING NA

Supporting Treatment Access and Recovery Through Linkage and Support

NCT05713695

RECRUITING NA

A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings

NCT06118346

RECRUITING

Botulinum Toxin Therapy in Hidradenitis Suppurativa

NCT05403710

RECRUITING NA

Supporting Treatment Access and Recovery in COD

NCT05138614

RECRUITING

SPIROMICS Study of Early COPD Progression (SOURCE)

NCT05033990

ACTIVE NOT RECRUITING NA

Adapting a Health at Every Size Intervention to Obstetric Care

NCT06919783

ACTIVE NOT RECRUITING NA

Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India

NCT07231432

ACTIVE NOT RECRUITING NA

Open Pilot Trial Evaluating an Avatar-Guided Intervention for Emerging Adults With Alcohol Use Problems and Suicide Risk

NCT06595862

ACTIVE NOT RECRUITING

Association of Digital Aid Use With Infant Sleep and Maternal Mental Health

NCT06593236

ACTIVE NOT RECRUITING NA

ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors

NCT05870176

ACTIVE NOT RECRUITING NA

Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI

NCT05671874

ACTIVE NOT RECRUITING NA

A Culturally Tailored Dietary Intervention to Treat Crohn's Disease

NCT05627128

ACTIVE NOT RECRUITING NA

Radiofrequency Ablation After Total Knee Arthroplasty

NCT05473663

ACTIVE NOT RECRUITING NA

nCCR for Chemotherapy Related Cognitive Impairment Randomized Study

NCT05283629

ACTIVE NOT RECRUITING

FORCE-TJR: Improving Orthopedic Outcomes Through a National TJR Registry

NCT02566473

NOT YET RECRUITING NA

Social Media and Risk-reduction Training for Preterm Infant Care Practices

NCT07420686

NOT YET RECRUITING NA

Study on Outcomes of Proximal Humerus Fractures

NCT07060664

NOT YET RECRUITING Phase 3

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

NCT07520110

NOT YET RECRUITING NA

Supporting Treatment Access and Recovery in Re-entry (STAR-R)

NCT07555145

NOT YET RECRUITING NA

Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts

NCT06100809

NOT YET RECRUITING NA

Lifestyle Change Implementation Research Network at PRC at UMass Chan

NCT07481305

NOT YET RECRUITING NA

Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes

NCT07637994

NOT YET RECRUITING NA

Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness

NCT06246539

NOT YET RECRUITING NA

Food is Medicine in Pediatric Patients With Diabetes

NCT07535502

COMPLETED

Prospective Evaluation of an Endoscopic Ultrasound (EUS)-Based Artificial Intelligence to Assist in the Deployment of Lumen Apposing Metal Stents for Gallbladder Drainage

NCT06981052

Page 1 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 24
Phase 2 14
Phase 3 11
Phase 4 12

What is open in the University of Massachusetts, Worcester pipeline

30 recruiting of 240 indexed (13% open); 177 completed (74%).

Phase mix: 23 late (III/IV) vs 38 early (I/II) (early-phase heavy).

Top condition: Alcohol Use Disorder (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Massachusetts, Worcester: open-pipeline peers nationwide

Peers matched on 240 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300 10%15%20%25% Total trials Recruiting share University of Massachusetts, WorcesterIncyte CorporationState University of New York at BuffaloLoma Linda UniversityDaiichi SankyoAddario Lung Cancer Medical InstituteAmerican UniversityAnnexonAnsun Biopharma
University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Massachusetts, Worcester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 240 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Massachusetts, Worcester page

240 registered trials is a research-attention snapshot, not an endorsement of University of Massachusetts, Worcester or any single study.

  • 30 of University of Massachusetts, Worcester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Alcohol Use Disorder is the condition University of Massachusetts, Worcester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Use Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Massachusetts, Worcester pipeline card: 240 registered trials from official public datasets.Report a data error.